Page 186 - MSU Digital Book
P. 186

14. Cyclophosphamide. [accessed 29 March 2020]. Available from: https://www.

                  accessdata.fda.gov/drugsatfda_docs/label/2013/012141s090,012142s112lbl.pdf.
                        ®
              15. Neoral . [accessed 29 March 2020]. Available from: https://www.accessdata.fda.
                  gov/drugsatfda_docs/label/2009/050715s027,050716s028lbl.pdf.

              16. Sandimmune . [accessed 29 March 2020]. Available from: https://www.accessdata.
                              ®
                  fda.gov/drugsatfda_docs/label/2015/050573s041,050574s051,050625s055lbl.pdf.

              17. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am
                  Soc Nephrol. 2009;4:481-508.
              18. Birnbaum LM, Lipman M, Paraskevas S, Chaudhury P, Tchervenkov P, Baran D, et

                  al. Management of chronic allograft nephropathy: a systematic review. CJASN.
                  2009;4:860-5.

              19. Oellerich M, Armstrong VW. Two-hour cyclosporine concentration determination:
                  an appropriate tool to monitor Neoral therapy? The Drug Monitor. 2002;24:40-6.
              20. Levy GA. C2 monitoring strategy for optimizing cyclosporine immunosuppression

                  from Neoral  formulation. BioDrugs. 2001;15:279-90.
                             ®
              21. Afinitor . [accessed 29 March 2020]. Available from: https://www.accessdata.fda.
                        ®
                  gov/drugsatfda_docs/label/2013/022334s022lbl.pdf.
              22. Immune globulin (IGIV). [accessed 29 March 2020]. Available from: https://www.
                  drugs.com/mtm/immune-globulin-intravenous-igiv.html.

              23. Methotrexate. [accessed 29 March 2020]. Available from: https://www.accessdata.
                  fda.gov/drugsatfda_docs/label/2016/008085s066lbl.pdf.

                             ®
              24. Solu-Medrol . [accessed 29 March 2020]. Available from: https://www.accessdata.
                  fda.gov/drugsatfda_docs/label/2011/011856s103s104lbl.pdf.
                          ®
              25. Cellcept . [accessed 29 March 2020]. Available from: https://www.accessdata.
                  fda.gov/drugsatfda_docs/label/2009/050722s021,050723s019,050758s019,05075
                  9s024lbl.pdf.

              26. Myfortic . [accessed 29 March 2020]. Available from: https://www.accessdata.fda.
                         ®
                  gov/drugsatfda_docs/label/2020/050791s030lbl.pdf.
              27. Davies NM, Grinyó J, Heading R, Maes B, Meier-Kriesche HU, Oellerich M. Gastroin-

                  testinal side effects of mycophenolic acid in renal transplant patients: a reappraisal.
                  Nephrol Dial Transplant. 2007;22:2440-8.






                                                                                            161
   181   182   183   184   185   186   187   188   189   190   191